CapsoVision (CV) Retained Earnings (2024 - 2025)

CapsoVision's (CV) quarterly Retained Earnings came in at -$155.7 million in Q4 2025, down 19.42% year-on-year from -$193.2 million in Q4 2024, and down 4.99% quarter-over-quarter from -$148.3 million in Q3 2025.

CapsoVision (CV) Retained Earnings (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Retained Earnings across 2 years of filings, most recently posting -$155.7 million for Q4 2025.

  • Retained Earnings for Q4 2025 came in at -$155.7 million, down 19.42% year-over-year; the trailing twelve-month figure through Dec 2025 was -$155.7 million (down 19.42% YoY), and the FY2025 annual result was -$155.7 million, down 19.42% from the prior year.
  • Retained Earnings came in at -$155.7 million for Q4 2025 at CapsoVision, down from -$148.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$130.4 million in Q4 2024 to a low of -$155.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 49.96 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -583.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 32.30 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -398.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -221.30 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 5.65 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 106.20 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -113.10 Mn
10 CapsoVision 176.55 Mn 166.44 Mn 1.95 Mn -155.67 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -155.67 Mn
Sep 30, 2025 -148.27 Mn
Jun 30, 2025 -140.35 Mn
Dec 31, 2024 -130.35 Mn